Vivos Inc (QB) (RDGL) News

Just the increase if 25 billion would put a $60 pps estimate value that's only 10% of cancer costs

Let's go RDGL

Yes imho it would require a material event 8K to be issued

SORRY I am so JADED but , big PHARMA does not WANT a cure for cancer and many other diseases
or they would be cured imho and I believe there are today KNOWN proven cures for cancer that have JUST BEEN SHELVED.
Sort of like the carburetor that was invented I think in the 60's that would get 100 mpg but the owner of the idea or patent sold it and it never hit the market. Then you have electrical generators using wheels and magnets and many other types of tech 4,000 PLUS APPLICATIONS SITTING IN THE US PATENT OFFICE TODAY

Just saying why would they kill their GOOSE that LAYS GOLDEN EGGS year in and year out

This should sum my opinion up pretty well

In 2023, the world spent $223 billion on cancer medicine, which is a 25 billion dollar increase from 2022. This is projected to increase to $409 billion by 2028.

If Vivos ever is offered a buyout/acquisition is that a material event that must be released to shareholders? Even if they turn it down , just curious.

MY TWO CENTS IS

I do NOT want RDGLto become acquired, I want to see this company reach it's height under the good DR, that has raised this baby and gotten it to NEW HEIGHTS.
NOT go to some big pharma that may just kill it off on the qt, because it dwarfs any of it's own cures or if you WILL TO KEEPs THEIR CASH FLOW RUNNING.
Had a friend that had to take some big pharma drug (can't remember whos) ever 3 months and it was like 27k$ per 1 CC.

BIG PHARMA doesn't want to sure cancer or they would be coming in NOW and begging to help us with whatever we needed, because it is their CASH COW

I think once we get FDA approval or phase 2 trial results in India are successful, Vivos could become a serious candidate for acquisition.

You are 100% correct.

In order to create the illusion that the Cov treatments were highly effective, the companies that were tasked with conducting the so called clinical trials routinely removed any enrolled patients from the study that had suffered mild-severe vax injuries, still got infected with Cov, or even died. .

They basically fudged the results in order to support the lie that the vax was 95%+ effective against the virus.


The total adverse events persons suffered from the C-vax exceeds the total from ALL previous vaxes combined, even with the alleged under reporting of injuries directly attributed to the C-vax!!!

hope 1$ PPS will be reached after IDE application approved

I've been making, in some cases attempting, strategic "Test Trades" for the past 2 weeks and it does indeed appear you are accurate.

Its being done methodically to avoid being noticed IMHO.

Yep, nice accumulation while things are quiet.

Slow accumulation today in anticipation of the 90 day human trial results, and the 30 day human trial results on the second set of patients?Quarterly/yearly update also due this month. I wouldn't be surprised if the IDE is submitted shortly after the 90 day is released.

It's the FDAs Job to say NO with the objective of saving "people" from harm or saving BIG PHARMA from losses in other ways.
How many people did FDA protect from harm during so called pandemic?
My understanding is the safety trials for BIG PHARMA were massive failures....not opinion but facts
FDA FUBARED

https://sharylattkisson.com/2024/01/watch-vaccine-trials/

https://www.nolo.com/legal-encyclopedia/libel-vs-slander-different-types-defamation.html

Really not a conspiracy now is it ...other studies indicate it was a Conspiracy

By your own admission, you don’t own shares—yet you’re scripting this unhinged fanfiction. ‘Underdosed tumors’ ruin Phase 1 safety? That’s not science—it’s a bad sci-fi flick where MK’s the villain twirling his mustache. Phase 1’s tolerability, not tumor Armageddon—India nailed it: December 2024, five patients thriving, gel flawless; February 2025, one tumor down 80%. Phase 2’s live—safety’s gold, and FDA pre-subs can peek at that, not ‘hidden.’ You’ve been spoon-fed this, yet you pitch ‘MK’s fool’s errand’ like a rejected movie pitch. No shares, no facts—just libelous B-movie lies from a sidelines heckler. ‘Hiding bad news’? Write a script with evidence or get off the stage—this flop’s canceled.

I get it. You're in denial that MK is well versed at screwing up with FDA. It's FDA's job to look for reasons to say no with the objective of protecting the public from harm. It's MK's job not to give them a reason to say no. Trying to sell FDA on accepting safety conclusions based on under dosed tumors is a fool's errand, but if MK wants to waste another year trying, so be it.

Heck, maybe the treated tumors in the initial 5 patients have all died by now, making the safety conclusions valid, but that wasn't the case at 30 days with the only patient MK has mentioned to date, and he remains silent on the subject. Is he hiding bad news again? Time will tell.

By your own admission, you don’t own shares—yet you’re peddling nonsense. Saying ‘underdosing’ voids safety in Phase 1? Ridiculous—Phase 1 tests tolerability, not max tumor-killing dose. India’s trial: December 2024, five patients safe, gel spot-on; February 2025, one tumor shrank 80%. Phase 2’s underway—safety passed. FDA pre-subs do let trial results get reviewed, so your ‘not seen’ excuse flops. You’ve been told: it’s not efficacy—yet you spin failure. No shares, no proof—just libelous trash. Show FDA rejection or quit.

MY BAD

Now this was a A TOTAL MIS READ OF A STATEMENT

Get serious RDGL is not hiring these folks imho,

BUT YES ANY COMPETITOR THAT WOULD HIRE bashers is pretty low life

I said MY WAG range was/is

$2.50-$5.00

but I will be here in a year to EAT CROW if if IFIN need be, I have salt pepper and hot sauce ready.

Even overall approval in INDIA could easily take us to the $2.5 range

We will both be here to see how it pans out

Simplistically RDGL at this point in time has one of the most non invasive safest devices/applications to treat tumorous cancers with apparently NO DAMAGE to surrounding tissues due to it's being locked/held in place and doesn't migrate throughout the body and cause further cell damage

And imho THE MAYO CLINIC doesn't just HOOK UP WITH ANY and ALL types of treatments, they are very selective with whom they take on associations with..

GO SAVE LIVESRDGL

Elon was obviously referring to the Betaglue company clod.


"ANd with this comment YOU APPEAR to be suggesting it is RDGL that is hiring these folks HMMMMMMMMMMMM Tell me what pray tell would they have ot gain doing tha"

You on here reminds me of the hilarious saying about the Pigeon playing Chess...........................

For grin and giggles KEEP IT CIVIL CYBIL this mb isn't for personal attacks LIKE SC8 outs out so don't grovel down to his level please

ANY with half a brain would know that shorts only affect share price not the company with a apparently very good product and so far very well received phase 1 trial result for safety.
And to be real honest whit associations with THE MAYO clinic just waiting to aide in further test, shorting would only benefit taking the pps down to accumulate, not try and annihilate a co with such a solid product. And NAKED short would be the way they do it, not real short.
Call your broker and see JUST HOW MUCH IT WOULD COST YOU TO LEGALLY SHORT 200K share of RDGL, YA best have DEEP POCKETS

ANd with this comment YOU APPEAR to be suggesting it is RDGL that is hiring these folks HMMMMMMMMMMMM Tell me what pray tell would they have ot gain doing that

What a sleazy company they must be to hire bashers to attack perceived competition.
I strongly recommend all RDGL shareholders stay away from this company and not INVEST A PENNY.

Please refrain from repLYING as I will no longer be seeing your posts TYIA

FDA won't see or review the India studies until MK submits an IDE application for USA human trials. Test results are not reviewed in the pre-sub program. So if MK wants to find out the hard way that FDA won't accept safety conclusions based on under dosed patients, so be it. He's well versed at messing up with FDA.

Last time we were on the cusp of US human trial approval in the market's eyes was around March 2012 on the charts, i think.

Different from then, is that we are already in Phase 2 human trials in India, FDA gave us marketing approval for all non human animals, we have more than a dozen vet clinics licensed to use our tech so safely they can kill a tumor from the back of a van in your driveway n FDA has already granted us Breakthru Device Designation (BDD) above and beyond all the thousands of other Brachytherapy devices out there...

Hmmmm, $2pps range could be low balling, lol.

-Go $RDGL

And yet you're the only one complaining, not the FDA, whom btw are fully aware of where the safety data is coming from.


Quote: "The FDA requires that clinical investigations outside the US meet good clinical practice (GCP) guidelines. This includes review and approval by an independent ethics committee (IEC) and informed consent from subjects."


You possess zero evidence that our India clinical trials do not comply with FDA standards so once again sceeate......., "YOU LOSE"!!! lololsss

What a silly Muppet you are.

GOB

My WAG is from $2.50-$5.00

You are having trouble focusing. What you said is totally incorrect.
If you take some "online learn how to read courses", they will teach you that I said the low- level foreign competition is hiring these bashers, and in addition a criminal enterprise may be involved due to the repeated lies this person writes in the group. His lies cater to short sellers.

$5.25 - this company and its products and how it can cure cancerous tumors is unparalleled and 47 and Bobby are going to unleash it all!  Golden Age is here bitches!  

My year n 1 day pps on my holdings is officially below the 52 week low, lol...
Any bets on what today's price looks like 1 year n 1 day from now?
-Go $RDGL

Get serious RDGL is not hiring these folks imho, market makers are to try and run folks away from it, so they can accumulate it for the next run. They will need a lot for shares on submission of the next filing of the application

By your own admission, you don’t own shares—yet you’re peddling more lies about Phase 1. You’ve been told repeatedly: it’s safety only, not efficacy—FDA 101, Google it. Phase 2’s rolling, meaning Phase 1 cleared safety. Your ‘tumors survived, so underdosed’ spiel? Nonsense—safety’s about tolerability, not tumor kill. December 2024: five patients fine, gel perfect. February 2025: one tumor shrank 80%. ‘Yin-yang’ efficacy-safety? Dead wrong for Phase 1. You’re not citing ‘common sense’—you’re spinning deliberate fiction to trash MK.

Exactly, phase 1 was safety. The only reason we learned anything about efficacy is because the results were encouraging and the company decided to share. We may not hear anything else about phase 1, it was a success and we are now in phase 2.

Again, it's just common sense. If the tumors survived treatment, it means they received less than required amount of radiation to do job, which in turn means surrounding healthy tissue didn't receive the amount of radiation as would be case if tumors had been properly treated. So any claims of safety demonstration in that case would be bogus.

Efficacy and safety are the ying and yang of this product. Can't determine one without the other. MK may waste more years arguing otherwise with FDA, something he's sadly done in past when they pointed out, contrary to his conclusions, that Dr. Fisher failed to demonstrate containment on rabbit tumors, hence why the work had to be repeated at JHU Vet School after MK gave up arguing otherwise. Note to date he has failed to submit that 2023 rabbit data to FDA, as that was in the withdrawn 2024 IDE application, and FDA doesn't review tests results in pre-submission program. So gotta wonder why he withdrew that application? Maybe the JHU data didn't line up with his conclusions?

https://www.nolo.com/legal-encyclopedia/libel-vs-slander-different-types-defamation.html

you keep lying about Phase 1. You’ve been told repeatedly it’s safety only, not efficacy—FDA rules, Google, everywhere. Phase 2’s underway, meaning Phase 1 passed. Still crying ‘underdosed’ and ‘no safety conclusions’? That’s not facts; it’s deliberate fiction to smear MK. Call it what you want—libel fits when you twist reality with no stake but spite.

By your own admission, you don’t own shares—yet you’re relentless with this libelous garbage. You’ve been told over and over in multiple conversations that Phase 1 is for safety only—not efficacy. It’s spelled out in FDA rules, every legit news source, Google—stuff any half-informed person grasps instantly. December 2024: five patients recovering well, gel placement flawless. February 2025: one tumor shrank 80%, a bonus for a safety trial, not the point. And here’s the kicker—Vivos is already in Phase 2 planning, meaning Phase 1 passed muster. Yet you’re still screeching ‘failure’ and ‘underdosed’ because tumors ‘survived,’ butchering a safety study into some efficacy fantasy it was never designed for. That’s not a mistake—you’re flat-out lying, twisting facts to smear MK and Vivos with zero stake but a clear grudge.
“‘Surrounding tissue underdosed’? ‘Can’t make safety conclusions’? Pure fiction—Phase 1 cleared, or Phase 2 wouldn’t be on deck. You’ve got no data, just wild guesses.

You mean libel. Can't slander someone in written forum. But it this case, I'm just citing the facts regarding MK's serial lying and demonstrated gross incompetence dealing with FDA. On what planet is that libel? Facts are facts

Again, can't make any valid safety conclusions if tumors were under dosed and survived treatment, as that means surround healthy tissue was also under dosed. Is incompetent MK going to waste more years arguing that kind of nonsense with FDA as he's done in past, or is he going to present a properly done safety study whenever he has the data and can bother to write it up?

Surely MK knows by now if tumors survived treatment or not. That must be known to make any safety conclusions. Yet he is silent. That's not a good sign. It is what it is.

RDGL has one "improved" process patent I know of and some "improved" application patents pending, none of which stop anyone from making a Radiogel offset, as all the original patents have expired. Moreover there is no evidence whatsoever of any performance advantages with MK's "improvements" vs the pre 2022 Radiogel.

It’s absolute defamation and slander

And that’s getting more bold by the day.

By your own admission], you don’t own shares—yet you’re relentless with this libelous onslaught. You’ve been told over and over in multiple conversations that Phase 1 is for safety only—not efficacy. It’s plastered across FDA guidelines, every credible news outlet, Google—basic stuff any half-informed person can find in ten seconds. December 2024: five patients recovering well, gel placement dead-on. February 2025: one tumor shrank 80%, a bonus for a safety trial, not the goal. Yet you keep bleating ‘failure’ because tumors aren’t dying fast enough, willfully mangling a safety study into some efficacy circus it was never meant to be. You’re not just wrong—you’re lying through your teeth, twisting reality to trash MK and Vivos. No shares, no stake—just a calculated smear job from someone too dishonest to admit what Phase 1 actually is. That’s not ignorance; it’s defamation with intent.

90 day human trial results of the first 5 patients expected this month. 30 day results of the second set of patients also due this month..
March is going to be one busy month for updates and PR's....

Yes, there is a board for NWL Newell Brands, they own Elmers,

Wrong again times 1000!! Pricing power is not limited.
RDGL HAS PATENTS/ Intellectual Property legally specific to their device and
medical protocols. This makes RDGL'S TECHNOLOGY EVEN MORE VALAUBLE!!

Is there a Betaglue board? Thought they were privately held. In any case, RDGL may have other competition we don't know of beyond Betaglue, but all have same problem as RDGL regardless of who is first to market. The tech is public domain now, so pricing power is limited.

They are also a competitor to Elmer's. Why don't you go to that board?

Wrong , you just promoted them again. What a sleazy company they must be to hire bashers to attack perceived competition.
I strongly recommend all RDGL shareholders stay away from this company and not INVEST A PENNY.

Dirty games and lies are wrong!!! They appear to be associating with a criminal element. Honest Investors should stick with RDGL, born in the USA!!!!!! AND A BRIGHT FUTURE ON THE HORIZON!!!

IsoPet is expanding, and trials in India are so far going well.

The best is yet to come!!!

I don't promote Betaglue or their product YntraDose. I do mention them because they are a direct RDGL competitor in this space, have a 2.5 year head start in clinical trials, and are much better funded than RDGL. Those facts make them a valid discussion topic here vs. RDGL.

For the record I receive no such compensation in any form. Just citing the facts regarding RDGL and the inept lying CEO, MK.

Again, can't make valid safety conclusions if tumors were under dosed. Hence why FDA wanted dosage put to bed before they would consider an IDE application. MK claiming otherwise just further demonstrates his incompetence dealing with FDA.

Regarding MK's serial lying, it's just a well documented fact. I get it that you're in denial of basic well documented facts like his 2023 lie the rabbit testing had successfully concluded when it remained ongoing, or his lie the rabbit write up would take 6 weeks when he took a year to write up (and still hasn't submitted cuz he withdrew the 2024 IDE application), or his 2021 lie he would submit IDE application no later than Sept 21, 2021, etc. Your denials don't change the fact MK is a proven serial liar per his own downdates going back years now. It is what it is.

I don't agree.

It's a little deeper than just getting someone to respond.

It's about bashing a company to cater to short sellers and criminal organizations, as well as getting people to invest in the glue stick company.

Very sleazy and dishonest!!!!!

But he ONLY GETS PAID if he gets responses thats how that game works

I have a strong feeling he is being paid by the amount of posts he makes per day/ week. Hence, he keeps on repeating the same thing over and over, even when clear/ TRUTHFUL answers about RDGL are provided to him. (Obviously trying to fill a volume quota which is based on a salary contract with the Glue stick company he keeps conveniently name dropping).

RDGL HAS A GREAT FUTURE!!! Foreign companies/ low level competition who retain stock bashers should never be invested in, or trusted.

IsoPet has a very bright future and has laid the groundwork for human trials in India, and one day in the United States.